SCHEMBL6568641

SCHEMBL6568641

O=C(Nc1cc(Cl)c(O)c(Cl)c1)C(C1CCCCC1)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.53
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
HPGD P15428 1/20 0.49
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
LMNA P02545 2/20 0.42
HTR1E P28566 2/20 0.42
S1PR3 Q99500 2/20 0.42
MAPT P10636 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
DHODH Q02127 1/20 0.41
HTT P42858 3/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EPHX2 P34913 1/20 0.41
CXCR2 P25025 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4347065 0.77 RAB9A (0.66) ALDH1A1MEN1KMT2ALMNANPC1
SCHEMBL6568610 0.75 RAB9A (0.63) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL4348625 0.71 SMN1; SMN2 (0.71) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6567255 0.71 EPHX2 (0.59) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6568672 0.71 ALDH1A1 (0.47) S1PR1ALDH1A1KDM4EHPGDMEN1
SCHEMBL6565535 0.71 ALDH1A1 (0.53) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL4345960 0.71 EPHX1 (0.64) S1PR1ALDH1A1KDM4EHPGDMEN1
SCHEMBL2860414 0.70 S1PR1 (1.00) S1PR1
SCHEMBL6565598 0.69 SMN1; SMN2 (0.68) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL4352945 0.69 RAB9A (0.59) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed